Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Agape ATP Corporation (ATPC : NSDQ)

• Company Description    AGAPE ATP CORPORATION is primarily operating in ASEAN region which supplies wellness products and health solution advisory services, including supplements to assist in cell metabolism, detoxification, blood circulation, anti-aging and products designed to improve the overall health system of the human body. AGAPE ATP CORPORATION is based in KUALA LUMPUR, MALAYSIA. Number of Employees: 18

• Price / Volume Information    Yesterday's Closing Price: $2.78 Daily Weekly Monthly 20 Day Moving Average: 2,431,212 shares Shares Outstanding: 1.00 (millions) Market Capitalization: $2.78 (millions) Beta: -0.92 52 Week High: $119.00 52 Week Low: $1.72 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 23.56% 17.52% 12 Week 51.91% 40.44% Year To Date -47.79% -38.02%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 1705-1708 LEVEL 17 TOWER 2 FABER TOWER JALAN DESA BAHAGIA TAMAN DESA - KUALA LUMPUR,N8 58100 - ph: 60-1-9223-0099 fax: - None http://www.atpc.com.my

• General Corporate Information    Officers How Kok Choong - Chief Executive Officer; President; Chief Operatin Andrew Lee Kam Fan - Chief Financial Officer Wilfrendo Fernando Cortizo - Director Ramesh Ruben Louis - Director Ni Luh Dharma Kerti Natih - Director Peer Information Agape ATP Corporation (BJCT) Agape ATP Corporation (CADMQ) Agape ATP Corporation (APNO) Agape ATP Corporation (UPDC) Agape ATP Corporation (IMTIQ) Agape ATP Corporation (CYGN) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED PRODUCTS Sector: Medical CUSIP: 008389306 SIC: 8000 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/26 Next Expected EPS Date: 08/12/26 Share - Related Items Shares Outstanding: 1.00 Most Recent Split Date: 2.00 (0.02:1) Beta: -0.92 Market Capitalization: $2.78 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/12/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 0.13 Price/Cash Flow: - Price / Sales: 1.84 EPS Growth vs. Year Ago Period: 90.57% vs. Previous Quarter: -% Sales Growth vs. Year Ago Period: -5.19% vs. Previous Quarter: -31.33% ROE 03/31/26 - -8.43 12/31/25 - -9.91 09/30/25 - -15.10 ROA 03/31/26 - -7.75 12/31/25 - -9.29 09/30/25 - -14.06 Current Ratio 03/31/26 - 9.01 12/31/25 - 11.82 09/30/25 - 16.21 Quick Ratio 03/31/26 - - 12/31/25 - 11.81 09/30/25 - 16.18 Operating Margin 03/31/26 - -126.56 12/31/25 - -150.56 09/30/25 - -183.38 Net Margin 03/31/26 - -125.89 12/31/25 - -149.90 09/30/25 - -183.38 Pre-Tax Margin 03/31/26 - -128.01 12/31/25 - -151.25 09/30/25 - -186.14 Book Value 03/31/26 - 22.06 12/31/25 - 22.41 09/30/25 - 22.80 Inventory Turnover 03/31/26 - 20.80 12/31/25 - 19.56 09/30/25 - 17.67 Debt-to-Equity 03/31/26 - 0.00 12/31/25 - 0.00 09/30/25 - 0.00 Debt-to-Capital 03/31/26 - 0.43 12/31/25 - 0.45 09/30/25 - 0.45

Powered by Zacks Investment Research ©